Release Date: 29/02/12 13:00 Summary: Bullabulling Resource Upgrade - 29 Feb 2012 Price Sensitive: Yes Download Document 429.97KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%